THROMBOSPONDIN 2--STRUCTURE EXPRESSION AND FUNCTION
THROMBOSPONDIN 2--STRUCTURE EXPRESSION AND FUNCTION
批准号:
2098861
负责人:
VISHVA M DIXIT
金额:
$25.25万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-04 至 1997-05-31
关键词:
RNA biosynthesis affinity chromatography arteriosclerosis autoradiography binding proteins biological products biotechnology cell growth regulation chemical binding extracellular matrix fibroblasts gel electrophoresis gene expression gene mutation genetic manipulation genetic mapping genetic promoter element genetic recombination genetic transcription heparin immunoprecipitation laboratory mouse laboratory rabbit messenger RNA molecular cloning monoclonal antibody neoplastic cell culture for noncancer research nucleic acid hybridization nucleic acid probes nucleic acid sequence online computer plasmids plasminogen platelet derived growth factor platelets protein biosynthesis protein sequence protein structure radiotracer regulatory gene reporter genes thrombosis thrombospondins tissue /cell culture vascular smooth muscle
中文摘要
人血小板凝血酶原蛋白(TSP)是一种高分子量
由三个相同的二硫键组成的糖蛋白(Mr 450,000)
键合的多肽链。TSP是血小板α-亚基的一种成分
颗粒和第二阶段的基本成分
血小板聚集。TSP还由多种细胞合成
包括平滑肌细胞、内皮细胞和成纤维细胞。
在这些细胞中,合成的TSP被分泌和掺入。
进入细胞外基质(ECM)。然而,有一些
最近的研究表明,TSP可能起到调节主动脉的作用
平滑肌细胞(SMC)生长。TSP也可以作为焦点
通过其结合两者的能力在ECM中产生蛋白酶
纤溶酶原和组织型纤溶酶原激活物(t-PA)。
因为TSP是血小板和血管壁的组成部分
参与了血小板-血小板和血小板血管的相互作用
它的研究应该有助于更好地理解它的作用
生理和病理状态(血栓形成、动脉粥样硬化)。
为了获得更多关于结构和
TSP在管壁中合成的调节
建议:1)研究肝素结合的作用
TSP与主动脉平滑肌细胞的结构域(HBD)
成长。这些研究将使用一种细菌表达系统,
合成HBD。隔离的HBD将被用于研究其
在主动脉平滑肌细胞增殖中的作用。2)对网络环境的研究
TSP的基因结构,以更好地了解TSP的组织和
基因的进化。解决的问题将包括:a)是否
分离功能结构域的外显子编码?B)TSP基因
通过基因复制等机制进化成现在的形式
和外显子改组?3)研究
血小板衍生生长因子(PDGF)促进TSP合成
PDGF是否通过增加血管内皮细胞TSP基因表达而增加TSP基因的表达?
转录速率或通过稳定TSP?4的mRNA)
定义TSP基因中的PDGF响应元件
由假定的调节性基因组成的基因结构
与报告基因(细菌氯霉素乙酰基)融合的区域
转移酶(CAT))。5)研究TSP与TSP的相互作用
利用纯化蛋白和分离的主动脉SMC制备纤溶酶原
矩阵。6)开发利用TSP的癌细胞的能力
作为尝试定位细胞结合的附着因素
TSP上的域。
英文摘要
Human platelet thrombospondin (TSP) is a high molecular weight
glycoprotein (Mr 450,000) composed of three identical disulphide
bonded peptide chains. TSP is a constituent of platelet alpha-
granules and an essential component of the secondary phase of
platelet aggregation. TSP is also synthesized by a variety of cells
including smooth muscle cells, endothelial cells and fibroblasts.
In these cells the synthesized TSP is secreted and incorporated
into the extracellular matrix (ECM). However there is some
recent work which suggests that TSP may serve to regulate aortic
smooth muscle cell (SMC) growth. TSP may also serve as a focus
for protease generation in the ECM by its ability to bind both
plasminogen and tissue plasminogen activator (t-PA).
Since TSP is constituent of both the platelet and the vessel wall
and involved in platelet-platelet and platelet vessel interactions
its study should contribute to the better understanding of its role
in both physiologic and pathologic states (thrombosis, atheroma).
In order to gain greater knowledge about the structure and
regulation of TSP synthesis in the vessel wall the following studies
are proposed: 1) Investigation of the role of the heparin binding
domain (HBD) of TSP with respect to aortic smooth muscle cell
growth. These studies will use a bacterial expression system that
synthesizes the HBD. The isolated HBD will be used to study its
role in aortic smooth muscle cell proliferation. 2) Study of the
gene structure of TSP to better understand the organization and
evolution of the gene. Questions addressed will include, a) Do the
exons code for seperate functional domains? b) Did the TSP gene
evolve to its present form by mechanisms such as gene duplication
and exon shuffling? 3) Investigate the mechanism by which
platelet derived growth factor (PDGF) increases TSP synthesis in
aortic SMC's. Does PDGF increase TSP mRNA by increasing the
transcriptional rate or by stabilizing the mRNA for TSP? 4)
Define the PDGF responsive elements within the TSP gene by use
of gene constructions that consist of the putative regulatory
region fused to a reporter gene (bacterial chloramphenicol acetyl
transferase (CAT)). 5) Study the interaction of TSP with
plasminogen using purified proteins and isolated aortic SMC
matrices. 6) Exploit the ability of carcinoma cells which use TSP
as an attachment factor in trying to localize the cell binding
domain on TSP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
B61 IN INFLAMMATION AND DEVELOPMENT
-
批准号:6238938
-
项目类别:
-
资助金额:$4.83万
-
财政年份:1997
-
负责人:VISHVA M DIXIT
-
依托单位:
SIGNAL TRANSDUCTION BY THE ECK RECEPTOR TYROSINE KINASE
-
批准号:2430280
-
项目类别:
-
资助金额:$21.43万
-
财政年份:1996
-
负责人:VISHVA M DIXIT
-
依托单位:
SIGNAL TRANSDUCTION BY THE ECK RECEPTOR TYROSINE KINASE
-
批准号:2152830
-
项目类别:
-
资助金额:$20.6万
-
财政年份:1996
-
负责人:VISHVA M DIXIT
-
依托单位:
FAS ASSOCIATED DEATH DOMAIN (FADD)
-
批准号:2376204
-
项目类别:
-
资助金额:$18.06万
-
财政年份:1996
-
负责人:VISHVA M DIXIT
-
依托单位:
CD40 SIGNAL TRANSDUCTION
-
批准号:2207431
-
项目类别:
-
资助金额:$19.42万
-
财政年份:1996
-
负责人:VISHVA M DIXIT
-
依托单位:
CD40 SIGNAL TRANSDUCTION
-
批准号:2403569
-
项目类别:
-
资助金额:$16.24万
-
财政年份:1996
-
负责人:VISHVA M DIXIT
-
依托单位:
FAS ASSOCIATED DEATH DOMAIN (FADD)
-
批准号:2055674
-
项目类别:
-
资助金额:$17.49万
-
财政年份:1996
-
负责人:VISHVA M DIXIT
-
依托单位:
ERB-B-2 EXPRESSION AND RESISTANCE TO TNF KILLING
-
批准号:2443110
-
项目类别:
-
资助金额:$20.11万
-
财政年份:1994
-
负责人:VISHVA M DIXIT
-
依托单位:
ERB-B-2 EXPRESSION AND RESISTANCE TO TNF KILLING
-
批准号:2107491
-
项目类别:
-
资助金额:$18.2万
-
财政年份:1994
-
负责人:VISHVA M DIXIT
-
依托单位:
ERB-B-2 EXPRESSION AND RESISTANCE TO TNF KILLING
-
批准号:2107493
-
项目类别:
-
资助金额:$19.49万
-
财政年份:1994
-
负责人:VISHVA M DIXIT
-
依托单位:
ERB-B-2 EXPRESSION AND RESISTANCE TO TNF KILLING
-
批准号:2107492
-
项目类别:
-
资助金额:$18.84万
-
财政年份:1994
-
负责人:VISHVA M DIXIT
-
依托单位:
NOVEL ZINC FINGER PROTEIN THAT INHIBITS TNF CYTOTOXICITY
-
批准号:2102090
-
项目类别:
-
资助金额:$27.09万
-
财政年份:1993
-
负责人:VISHVA M DIXIT
-
依托单位:
NOVEL ZINC FINGER PROTEIN THAT INHIBITS TNF CYTOTOXICITY
-
批准号:2102089
-
项目类别:
-
资助金额:$25.98万
-
财政年份:1993
-
负责人:VISHVA M DIXIT
-
依托单位:
NOVEL ZINC FINGER PROTEIN THAT INHIBITS TNF CYTOTOXICITY
-
批准号:3204813
-
项目类别:
-
资助金额:$24.05万
-
财政年份:1993
-
负责人:VISHVA M DIXIT
-
依托单位:
NOVEL ZINC FINGER PROTEIN THAT INHIBITS TNF CYTOTOXICITY
-
批准号:2102088
-
项目类别:
-
资助金额:$24.51万
-
财政年份:1993
-
负责人:VISHVA M DIXIT
-
依托单位:
THROMBOSPONDIN 2; STRUCTURE EXPRESSION AND FUNCTION
-
批准号:3202426
-
项目类别:
-
资助金额:$25.14万
-
财政年份:1992
-
负责人:VISHVA M DIXIT
-
依托单位:
THROMBOSPONDIN 2; STRUCTURE EXPRESSION AND FUNCTION
-
批准号:3202427
-
项目类别:
-
资助金额:$21.13万
-
财政年份:1992
-
负责人:VISHVA M DIXIT
-
依托单位:
THROMBOSPONDIN 2--STRUCTURE EXPRESSION AND FUNCTION
-
批准号:2098862
-
项目类别:
-
资助金额:$26.23万
-
财政年份:1992
-
负责人:VISHVA M DIXIT
-
依托单位:
HEPARIN AND AORTIC SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:3367033
-
项目类别:
-
资助金额:$13.49万
-
财政年份:1992
-
负责人:VISHVA M DIXIT
-
依托单位:
THROMBOSPONDIN 2--STRUCTURE EXPRESSION AND FUNCTION
-
批准号:2098863
-
项目类别:
-
资助金额:$27.92万
-
财政年份:1992
-
负责人:VISHVA M DIXIT
-
依托单位:
海外基金